(Q42018917)

15 October 2017

Effects of CYP2C9*1/*13 on the pharmacokinetics and pharmacodynamics of meloxicam (English)

1 reference

15 October 2017

1 reference

1 reference

Jung-Woo Bae

1

1 reference

15 October 2017

Chang-Ik Choi

series ordinal

2

1 reference

15 October 2017

Choon-Gon Jang

series ordinal

3

1 reference

15 October 2017

Seok-Yong Lee

series ordinal

4

1 reference

15 October 2017

language of work or name

English

0 references

publication date

1 April 2011

1 reference

British Journal of Clinical Pharmacology

15 October 2017

1 reference

15 October 2017

71

1 reference

15 October 2017

4

1 reference

15 October 2017

550-555

1 reference

Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups

15 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080643

On the human CYP2C9*13 variant activity reduction: a molecular dynamics simulation and docking study

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080643

CYP2C9, CYP2C19, ABCB1 (MDR1) genetic polymorphisms and phenytoin metabolism in a Black Beninese population

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080643

Allele and genotype frequencies of CYP2C9 in a Korean population

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080643

Role of CYP2C9 and its variants (CYP2C9*3 and CYP2C9*13) in the metabolism of lornoxicam in humans

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080643

CYP2C9 allelic variants: ethnic distribution and functional significance

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080643

Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080643

Clinical relevance of genetic polymorphisms in the human CYP2C subfamily

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080643

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080643

Clinical pharmacokinetics of meloxicam.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080643

A review of the clinical pharmacokinetics of meloxicam

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080643

Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080643

Piroxicam. A reappraisal of its pharmacology and therapeutic efficacy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080643

Effects of the CYP2C9*13 allele on the pharmacokinetics of losartan in healthy male subjects.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080643

Substrate-dependent functional alterations of seven CYP2C9 variants found in Japanese subjects.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080643

Effect of CYP2C9 and VKORC1 genotypes on early-phase and steady-state warfarin dosing in Korean patients with mechanical heart valve replacement

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080643

Determination of meloxicam in human plasma using a HPLC method with UV detection and its application to a pharmacokinetic study

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080643

Four novel defective alleles and comprehensive haplotype analysis of CYP2C9 in Japanese.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080643

Catalytic activities of human cytochrome P450 2C9*1, 2C9*3 and 2C9*13.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080643

A non-extracting procedure for the determination of meloxicam in plasma samples by HPLC-diode array detection

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080643

Identification of a novel variant CYP2C9 allele in Chinese

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080643

Identification of a null allele of CYP2C9 in an African-American exhibiting toxicity to phenytoin

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080643

Power and sample size calculations for studies involving linear regression

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080643

Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080643

Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects

17 August 2018

1 reference

12 December 2020

The effect of cholestyramine on the pharmacokinetics of meloxicam, a new non-steroidal anti-inflammatory drug (NSAID), in man

1 reference

12 December 2020

Meloxicam: influence on arachidonic acid metabolism. Part 1. In vitro findings

1 reference

12 December 2020

Meloxicam: influence on arachidonic acid metabolism. Part II. In vivo findings

1 reference

12 December 2020

Pharmacokinetics and metabolic pattern after intravenous infusion and oral administration to healthy subjects

1 reference

12 December 2020

'Pavlovian' food effect on the enterohepatic recirculation of piroxicam

1 reference

12 December 2020

Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1

1 reference

12 December 2020

Metabolism of Meloxicam in human liver involves cytochromes P4502C9 and 3A4

1 reference

12 December 2020

Comparison of inhibitory effects of meloxicam and diclofenac on human thromboxane biosynthesis after single doses and at steady state

1 reference

12 December 2020

10.1111/J.1365-2125.2010.03853.X

Identifiers

DOI

1 reference

15 October 2017

1 reference

15 October 2017

PubMed publication ID

21395648

1 reference